These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metastatic clear cell renal cell carcinoma: A review of current therapies and novel immunotherapies. Thomas JS; Kabbinavar F Crit Rev Oncol Hematol; 2015 Dec; 96(3):527-33. PubMed ID: 26299335 [TBL] [Abstract][Full Text] [Related]
3. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer. Parton M; Gore M; Eisen T J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma. Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106 [TBL] [Abstract][Full Text] [Related]
10. Novel immunotherapeutic strategies in development for renal cell carcinoma. Inman BA; Harrison MR; George DJ Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for renal cell cancer. Yang JC; Childs R J Clin Oncol; 2006 Dec; 24(35):5576-83. PubMed ID: 17158543 [TBL] [Abstract][Full Text] [Related]
13. Immunotherapy and targeted therapies in metastatic renal cell carcinoma: is there a preferred sequence? Giuliani J; Drudi F Cancer Biother Radiopharm; 2012 Oct; 27(8):513-8. PubMed ID: 22738404 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapeutic strategies in kidney cancer--when TKIs are not enough. Biswas S; Eisen T Nat Rev Clin Oncol; 2009 Aug; 6(8):478-87. PubMed ID: 19546865 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for metastatic renal cell carcinoma: is it a therapeutic option yet? Guida M; Colucci G Ann Oncol; 2007 Jun; 18 Suppl 6():vi149-52. PubMed ID: 17591810 [TBL] [Abstract][Full Text] [Related]
16. Immune therapy for kidney cancer: a second dawn? McDermott DF; Atkins MB Semin Oncol; 2013 Aug; 40(4):492-8. PubMed ID: 23972713 [TBL] [Abstract][Full Text] [Related]
18. Can vaccination or tyrosine kinase inhibitor therapy play a role in the adjuvant treatment of renal cell carcinoma? Brookman-May S; May M; Gilfrich C; Wieland WF; Burger M Expert Rev Anticancer Ther; 2010 Jun; 10(6):813-23. PubMed ID: 20553207 [TBL] [Abstract][Full Text] [Related]